JOINT FILING AND ADVOCACY AGREEMENTJoint Filing and Advocacy Agreement • June 1st, 2022 • Camac Fund, LP • Pharmaceutical preparations • Delaware
This joint filing and advocacy agreement (this “Agreement”), dated as of May 31, 2022 (the “Effective Date”), is between (a) Concord IP2 Ltd., Elderhill Corporation and David Delaney (collectively the “Concord Persons”); (b) Leonite Capital, LLC and Avi Geller (collectively, the “Leonite Persons”); and (c) Camac Partners, LLC, Camac Capital, LLC, Camac Fund, LP and Eric Shahinian (collectively, the “Camac Persons”). The parties to this Agreement are each referred to as a “Party.”
